Aarkstore Enterprise Angelini Pharmaceuticals - Product Pipeline Review - Q4 2010

Aarkstore announce a new report "Angelini Pharmaceuticals - Product Pipeline Review

- Q4 2010" through its vast collection of market research report.

Angelini Pharmaceuticals - Product Pipeline Review - Q4 2010 provides data on the companys research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together.

Scope

- Angelini Pharmaceuticals - Brief company overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of Angelini Pharmaceuticals human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Angelini Pharmaceuticals with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the Angelini Pharmaceuticalss pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Angelini Pharmaceuticalss strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of Angelini Pharmaceuticals in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the Angelini Pharmaceuticalss R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Angelini Pharmaceuticals.

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Angelini Pharmaceuticals and identify potential opportunities in those areas.

For more information, please visit:

http://www.aarkstore.com/reports/Angelini-Pharmaceuticals-Product-Pipeline-Review-Q4-2010-86477.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise Apricus Biosciences, Inc - Product Pipeline Review - Q4 2010 Protect Your Wealth and Success Through Astro Products: Aarkstore Enterprise Halcygen Pharmaceuticals Limited - Product Pipeline Review - Q4 2010 Aarkstore Enterprise Sylentis Product Pipeline Review Q4 2010 Renaissance Costumes Era Fashion 3d Tv Reviews - What To Consider When Shopping For 3d Tvs Aarkstore Enterprise Tamir Biotechnology, Inc Product Pipeline Review Q4 2010 Methods To Accessorize Your Prom Dress Part 1 Girls Leather Jackets to Die For 1Shopping Cart SEO How Gucci Got Started Duffle carrier with Wheels - Mobility with Fashion Leather Duffle Bags: An Excellent Investment